emtricitabine/tenofovir/efavirenz

Also known as efavirenz / emtricitabine / tenofovir disoproxil fumarate, efavirenz / emtricitabine / tenofovir disoproxil, Atripla

Efavirenz/emtricitabine/tenofovir, sold under the brand name Atripla among others, is a fixed-dose combination antiretroviral medication used to treat HIV/AIDS. It contains efavirenz, emtricitabine, and tenofovir disoproxil. It can be used by itself or together with other antiretroviral medications. It is taken by mouth.

Key facts

Drug.verifiedrevid: 447573543
Drug.drug_name: Efavirenz/emtricitabine/tenofovir disoproxil
Drug.type: combo
Drug.image: Efavirenz, emtricitabine and tenofovir disoproxil.svg
Drug.image_class: skin-invert-image
Drug.component1: Efavirenz
Drug.class1: non-nucleoside reverse transcriptase inhibitor
Drug.component2: Emtricitabine
Drug.class2: nucleoside analog reverse transcriptase inhibitor
Drug.component3: Tenofovir disoproxil
Drug.class3: nucleotide analog reverse transcriptase inhibitor
Drug.tradename: Atripla, Viraday, others

~4 min read

Article

8 sections

Contents

Medical uses
Contraindications
Side effects
Interactions
Mechanism of action
History
Society and culture
References

Common side effects include headache, trouble sleeping, sleepiness, and unsteadiness. Serious side effects may include high blood lactate levels, psychiatric symptoms, and enlargement of the liver. It should not be used in children. If used during the first trimester of pregnancy harm to the baby may occur.